June 7, 2016
We asked Matt Gattuso, our new President of PDI Infection Prevention, a few questions about his background as well as his thoughts on the healthcare industry. Read what he had to say:
Tell us a little bit about your background.
I was born and raised in Massachusetts – and yes, will make no apologies for being a diehard Boston sports fan! I realize this declaration may not easily endear me to folks with rooting interests in NY sports teams but I’m hopeful it demonstrates a glimpse into my leadership style. Authenticity, transparency, passion and loyalty are critically important to be successful in business – and in sports, even as a fan.
From a business perspective, I was blessed with a twenty year career at Covidien (acquired by Medtronic in 2015) where I had the opportunity to lead teams in a highly matrixed organization across numerous channels and areas of care, including acute care, extended care, animal health, dental and consumer markets. Additionally, my responsibilities included distribution, national accounts and IDNs for the legacy Covidien organization which afforded me unique opportunities to build deep, meaningful relationships with the same trading partners who we rely on at PDI to implement cost-effective, transformational solutions.
On a personal note, I’ve been happily married to my wife, Stephanie, for twenty years and have three active teenage boys, Grant (15), Blake (14) and Gavin (14).
In your opinion, what has been the biggest impact on infection prevention within the last 5 years?
In my opinion, the most notable change in healthcare, and to a great extent in the infection prevention arena, is the shift to the new fee-for-value payment models that are replacing traditional fee-for-service programs. These changes impact the way hospitals are reimbursed and eliminate their ability to receive additional payments for patients who are readmitted to the hospital due preventable complications, such as hospital acquired infections (HAIs). As a result, clinicians and hospital administrators have a greater financial incentive to reduce or eliminate HAIs in their facilities.
What do you see as the biggest challenge for hospitals and infection prevention in the coming years?
The "superbugs" that continue to emerge and how we can stay ahead of the game is an issue for the industry in general. As a leader in the infection prevention industry, it’s our responsibility to be both innovative and nimble to help clinicians ‘see around corners’ and provide them with the best solutions possible to fight preventable infections.
What attracted you to PDI?
First and foremost, the people…building a great organization starts with having great people – and PDI certainly has some of the best in the industry. I was also inspired by the focused vision and passion to "Be the Difference". It’s such a clear, compelling and actionable mission to align our efforts with clinicians and trading partners in healthcare, food safety and community settings to eliminate preventable infections.
What makes you most excited for the future of PDI?
I’m excited for the opportunity explore unchartered waters with my new colleagues here at PDI. I understand the deep history of the organization and our charter to minimize organizational risk – so I will certainly not be reckless or cavalier in my approach. That being said, I firmly believe we need to step outside our comfort zone to accelerate our ability to bring innovative products and solutions to market that will help prevent common, costly and deadly complications resulting from preventable infections. Clinicians, patients and the food safety community our counting on us to do just that. I couldn’t be more excited about our future!